Human Genome Sciences Submits Biologics License Application To FDA For ABthrax(TM) (Medical News Today)
Human Genome Sciences, Inc. (Nasdaq: HGSI) announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its human monoclonal antibody drug ABthrax(TM) (raxibacumab) for the treatment of inhalation anthrax.

FDA Approves Samsca For The Treatment Of Hyponatremia (Medical News Today)
The FDA (Food and Drug Administration) has approved Samsca (tolvaptan), in tablet form, for the treatment of hyponatremia. Hyponatremia is when levels of sodium in the blood are abnormally low - it is associated with dehydration. Norman Stockbridge, M.D.